SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : The Trump Presidency
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: i-node who wrote (192769)1/30/2021 8:23:25 PM
From: J_F_Shepard  Read Replies (2) of 361488
 

Epidemiologist Harvey Risch, at Yale, has complied a large number of studies proving it works.


YSPH professor criticized for promoting unproven drug to treat COVID-19

Charlotte Zimmer 5:33 pm, Aug 16, 2020

Staff Reporter

Yale School of Public Health professor Harvey Risch has been a vocal supporter of the use of hydroxychloroquine to treat COVID-19, despite a lack of scientific evidence that it works.

In a July 23 opinion piece in Newsweek, Risch argued for the use of hydroxychloroquine, in combination with the antibiotic azithromycin, to treat high-risk COVID-19 patients without waiting for further testing on the effectiveness of the treatment. He published this piece after his May 27 paper in the American Journal of Epidemiology was widely criticized due to a lack of evidence from randomized trials. Both articles argued this combination of drugs can effectively prevent hospitalization for most symptomatic high-risk outpatients and that it is safe for short-term use early in the course of infection. This claim is now widely disputed.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News